NEW YORK (
) hit a new 52-week low Thursday as it traded at $29.25 compared with its previous 52-Week low of $29.32. ResMed is changing hands at $29.25 with 286,700 shares traded as of 10:12 a.m. ET. Average volume has been 1.2 million shares over the past 30 days.
ResMed has a market cap of $4.7 billion and is part of the
industry. Shares are down 14.2% year to date as of the close of trading on Wednesday.
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company has a P/E ratio of 22.1, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.
- Practice your RMD trading strategies and win cash in our stock game.
TheStreet Ratings rates ResMed as hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity. You can view the full
or get investment ideas from our